Danian J. Nie

No.107 Yanjiang West Road
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study.

Autologous transplant versus matched sibling donor transplant in intermediate-risk AML in CR1 with no detectable MRD: a biological assignment comparative study.

Journal: Experimental hematology & oncology

Published: March 25, 2026

Chinese guidelines on comprehensive assessment of clinical practice in hematopoietic stem cell transplantation Δ.

Chinese guidelines on comprehensive assessment of clinical practice in hematopoietic stem cell transplantation Δ.

Journal: Journal of cancer research and therapeutics

Published: December 02, 2025

Integration of a 4-gene risk score model enhances prognostic accuracy in acute myeloid leukemia.

Integration of a 4-gene risk score model enhances prognostic accuracy in acute myeloid leukemia.

Journal: Cell cycle (Georgetown, Tex.)

Published: October 30, 2025

Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

Journal: Biomarker research

Published: June 24, 2025

Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.

Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.

Journal: Experimental hematology & oncology

Published: April 22, 2025

High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.

High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.

Journal: Leukemia

Published: January 20, 2025

Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT.

Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT.

Journal: Blood cancer journal

Published: October 06, 2024

A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph+ acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study.

A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph+ acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study.

Journal: American journal of hematology

Published: July 14, 2024

The relationship between platelet parameters and bacterial types in patients with bacteremia: A retrospective observational study.

The relationship between platelet parameters and bacterial types in patients with bacteremia: A retrospective observational study.

Journal: Journal of infection in developing countries

Published: July 04, 2024

Activation of the HMGB1-TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia.

Activation of the HMGB1-TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia.

Journal: British journal of haematology

Published: April 28, 2024

Preclinical Short-term and Long-term Safety of Human Bone Marrow Mesenchymal Stem Cells.

Preclinical Short-term and Long-term Safety of Human Bone Marrow Mesenchymal Stem Cells.

Journal: Cell transplantation

Published: December 07, 2023

PHGDH is Key to a Prognostic Multigene Signature and a Potential Therapeutic Target in Acute Myeloid Leukemia.

PHGDH is Key to a Prognostic Multigene Signature and a Potential Therapeutic Target in Acute Myeloid Leukemia.

Journal: Journal of Cancer

Published: October 06, 2023

Showing 1-12 of 54

Last Updated: 09/26/2026